Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Too funny..doh Fluff, not even good fluff.

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Oct 05, 2021 3:55pm

158 Views

Post# 33968484

Too funny..doh Fluff, not even good fluff.

5-year plan (2022-2026) cumulative gross sales are expected to
reach $121M in Canada.

EXPECTED/BEST GUESS /MAYBE/ MIGHT/COULD BE

121,000,000 divided by 5 years is ONLY 24,200,000 a YEAR

Tetra can burn through that in a quarter, they spent 26 million 4th quarter of 2020.Pumpers can't do math or facts/company history very well, they are good at guessing,dreaming,cheering and drawing rockets and putting others down that just are looking for the truth and are realistic until there are RESULTS not a bunch of hype.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"